Table 3.

Multiple regression analysis with coronary artery score as the outcome variable.

Model	Liver stiffness (kPa)			Fibrosis-4 Index			NAFLD Fibrosis Score
	Regression coefficient	SE	p value	Regression coefficient	SE	p value	Regression coefficient	SE	p value
Unadjusted	0.289	0.118	0.018	1.227	0.775	0.120	0.840	0.292	0.006
1	0.288	0.116	0.017	1.063	0.782	0.180	0.824	0.288	0.006
2	0.286	0.121	0.022	1.194	0.812	0.148	0.862	0.294	0.005
3	0.276	0.115	0.021	0.963	0.779	0.223	0.733	0.303	0.020
4	0.230	0.113	0.048	1.209	0.715	0.097	0.657	0.288	0.027
5	0.202	0.095	0.040	0.670	0.626	0.290	0.505	0.247	0.047
6	0.285	0.108	0.011	1.076	0.721	0.143	0.687	0.282	0.019
7	0.287	0.119	0.020	1.196	0.791	0.137	0.833	0.295	0.007
8	0.284	0.103	0.008	1.241	0.682	0.075	0.688	0.266	0.013
9	0.286	0.108	0.011	0.886	0.736	0.235	0.636	0.292	0.035
10	0.308	0.122	0.015	1.603	0.822	0.057	0.921	0.302	0.004
11	0.255	0.122	0.043	1.353	0.774	0.087	0.842	0.293	0.006
12	0.282	0.118	0.024	− 0.076	0.934	0.936	0.409	0.358	0.263
13	0.372	0.107	0.002	0.281	1.040	0.789	0.698	0.348	0.054
14	0.241	0.112	0.036	1.334	0.712	0.067	0.626	0.296	0.040
15	0.264	0.106	0.017	1.574	0.774	0.048	0.566	0.330	0.094

SE standard error. Model 1: adjusted for sex. Model 2: adjusted for carbohydrate intolerance. Model 3: adjusted for diabetes. Model 4: adjusted for hypertension. Model 5: adjusted for dyslipidaemia. Model 6: adjusted for obstructive sleep apnea syndrome. Model 7: adjusted for hyperuricemia. Model 8: adjusted for statin therapy. Model 9: adjusted for aspirin therapy. Model 10: adjusted for obesity. Model 11: adjusted for smoking. Model 12: adjusted for visceral adipose tissue. Model 13: adjusted for visceral adipose tissue/subcutaneous adipose tissue ratio. Model 14: adjusted for presence of carbohydrate intolerance, hypertension, dyslipidaemia, and obesity (number of factors). Model 15: adjusted for presence of carbohydrate intolerance/diabetes, hypertension, dyslipidaemia, and obesity (number of factors).